Evidence map›Paper›PMID 27659492›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2017

CB

Emilia Grzęda, Eberhard Schlicker, Marek Toczek, Iwona Zalewska, Marta Baranowska-Kuczko, Barbara Malinowska

Open access · hybridAbstract read
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Centrally administered thromboxane AScientific reports · 2025
    Article
  3. Article
  4. Pharmacognosy and Effects of Cannabinoids in the Vascular System.ACS pharmacology & translational science · 2022
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Serotonin and beyond-a tribute to Manfred Göthert (1939-2019).Naunyn-Schmiedeberg's archives of pharmacology · 2021
    Review
  10. Article
  11. Review
  12. The endocannabinoid system in cardiovascular function: novel insights and clinical implications.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Emilia GrzędaDepartment of Experimental Physiology and Pathophysiology, Medical University of Białystok, Białystok, Poland.
Eberhard SchlickerDepartment of Pharmacology and Toxicology, University of Bonn, Bonn, Germany.
Marek ToczekDepartment of Experimental Physiology and Pathophysiology, Medical University of Białystok, Białystok, Poland.
Iwona ZalewskaDepartment of Experimental Physiology and Pathophysiology, Medical University of Białystok, Białystok, Poland.
Marta Baranowska-KuczkoDepartment of Experimental Physiology and Pathophysiology, Medical University of Białystok, Białystok, Poland.
Barbara MalinowskaDepartment of Experimental Physiology and Pathophysiology, Medical University of Białystok, Białystok, Poland. bmalin@umb.edu.pl.
Medical University of Białystok · PLUniversity of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have shown previously that the cannabinoid receptor agonist CP55940 microinjected into the paraventricular nucleus of the hypothalamus (PVN) of urethane-anaesthetized rats induces depressor and pressor cardiovascular effects in the absence and presence of the CB

Indexed as

AdrenalectomyAnimalsBlood PressureCannabinoid Receptor AgonistsCyclohexanolsgamma-Aminobutyric AcidGlutamic AcidHeart RateHypertensionHypotensionMaleMicroinjectionsNeural InhibitionNeural PathwaysNitric OxideParaventricular Hypothalamic Nucleus3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanolCannabinoid Receptor AgonistsCnr1 protein, ratCyclohexanolsgamma-Aminobutyric AcidGlutamic AcidNitric OxideReceptor, Angiotensin, Type 1Receptor, Cannabinoid, CB1Receptors, Adrenergic, beta-2Receptors, Thromboxane A2, Prostaglandin H2Angiotensin AT1 receptorCannabinoid CB1 receptorGABAA receptorNMDA receptorParaventricular nucleus of hypothalamusβ2-adrenoceptor

Identifiers

PMID27659492
PMCPMC5203819
OpenAlexW2523328381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.